Literature DB >> 29622657

Fetal hemoglobin induction in sickle erythroid progenitors using a synthetic zinc finger DNA-binding domain.

Biaoru Li1, Xingguo Zhu1, Mir A Hossain2, Cameron R Guy2, Hongyan Xu3, Jörg Bungert4, Betty S Pace5,6.   

Abstract

Mesh：

Substances：

Year:  2018        PMID： 29622657      PMCID： PMC6119143          DOI： 10.3324/haematol.2017.185967

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  15 in total

Review 1.  Regulation of disease-associated gene expression in the 3D genome.

Authors:  Peter Hugo Lodewijk Krijger; Wouter de Laat
Journal:  Nat Rev Mol Cell Biol       Date:  2016-11-09       Impact factor: 94.444

2.  Genome Editing for Sickle Cell Disease: A Little BCL11A Goes a Long Way.

Authors:  Mir A Hossain; Jörg Bungert
Journal:  Mol Ther       Date:  2017-02-09       Impact factor: 11.454

3.  NRF2 mediates γ-globin gene regulation and fetal hemoglobin induction in human erythroid progenitors.

Authors:  Xingguo Zhu; Biaoru Li; Betty S Pace
Journal:  Haematologica       Date:  2017-05-04       Impact factor: 9.941

4.  MicroRNA-15a and -16-1 act via MYB to elevate fetal hemoglobin expression in human trisomy 13.

Authors:  Vijay G Sankaran; Tobias F Menne; Danilo Šćepanović; Jo-Anne Vergilio; Peng Ji; Jinkuk Kim; Prathapan Thiru; Stuart H Orkin; Eric S Lander; Harvey F Lodish
Journal:  Proc Natl Acad Sci U S A       Date:  2011-01-04       Impact factor: 11.205

5.  Original Research: Stable expression of miR-34a mediates fetal hemoglobin induction in K562 cells.

Authors:  Christina M Ward; Biaoru Li; Betty S Pace
Journal:  Exp Biol Med (Maywood)       Date:  2016-03-02

Review 6.  Curative approaches for sickle cell disease: A review of allogeneic and autologous strategies.

Authors:  Daniel E Bauer; Christian Brendel; Courtney D Fitzhugh
Journal:  Blood Cells Mol Dis       Date:  2017-09-01       Impact factor: 3.039

7.  Gene Therapy in a Patient with Sickle Cell Disease.

Authors:  Jean-Antoine Ribeil; Salima Hacein-Bey-Abina; Emmanuel Payen; Alessandra Magnani; Michaela Semeraro; Elisa Magrin; Laure Caccavelli; Benedicte Neven; Philippe Bourget; Wassim El Nemer; Pablo Bartolucci; Leslie Weber; Hervé Puy; Jean-François Meritet; David Grevent; Yves Beuzard; Stany Chrétien; Thibaud Lefebvre; Robert W Ross; Olivier Negre; Gabor Veres; Laura Sandler; Sandeep Soni; Mariane de Montalembert; Stéphane Blanche; Philippe Leboulch; Marina Cavazzana
Journal:  N Engl J Med       Date:  2017-03-02       Impact factor: 91.245

Review 8.  Intravascular hemolysis and the pathophysiology of sickle cell disease.

Authors:  Gregory J Kato; Martin H Steinberg; Mark T Gladwin
Journal:  J Clin Invest       Date:  2017-03-01       Impact factor: 14.808

9.  A T-to-G transversion at nucleotide -567 upstream of HBG2 in a GATA-1 binding motif is associated with elevated hemoglobin F.

Authors:  Zhiyi Chen; Hong-Yuan Luo; Raveen K Basran; Tien-Huei Hsu; Daniel W H Mang; Lalana Nuntakarn; Cathy G Rosenfield; George P Patrinos; Ross C Hardison; Martin H Steinberg; David H K Chui
Journal:  Mol Cell Biol       Date:  2008-04-28       Impact factor: 4.272

Review 10.  Minireview: Prognostic factors and the response to hydroxurea treatment in sickle cell disease.

Authors:  Winfred C Wang
Journal:  Exp Biol Med (Maywood)       Date:  2016-03-29
View more
  3 in total

1.  δ-Aminolevulinate induces fetal hemoglobin expression by enhancing cellular heme biosynthesis.

Authors:  Li Liu; Xingguo Zhu; Alexander Yu; Christina M Ward; Betty S Pace
Journal:  Exp Biol Med (Maywood)       Date:  2019-08-31

2.  Genome editing strategies for fetal hemoglobin induction in beta-hemoglobinopathies.

Authors:  Selami Demirci; Alexis Leonard; John F Tisdale
Journal:  Hum Mol Genet       Date:  2020-09-30       Impact factor: 6.150

3.  Salubrinal induces fetal hemoglobin expression via the stress-signaling pathway in human sickle erythroid progenitors and sickle cell disease mice.

Authors:  Nicole H Lopez; Biaoru Li; Chithra Palani; Umapathy Siddaramappa; Mayuko Takezaki; Hongyan Xu; Wenbo Zhi; Betty S Pace
Journal:  PLoS One       Date:  2022-05-31       Impact factor: 3.752
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.